Structure determination and biological activities of elaiophylin produced by Streptomyces sp. MCY-846

Journal of Microbiology and Biotechnology

Volumn 6, Issue 4, 1996, Pages 245-249

  Lee, Sang Yong ^a   Kim, Mi Soon ^b   Kim, Hang Sub ^b   Kim, Young Ho ^b   Hong, Soon Duck ^a   Lee, Jung Joon ^b  

^a Kyungpook National University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Antibacterial activity; Cytotoxicity; Elaiophylin; Nitric oxide

Indexed keywords

EID: 0008147311     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Arai, M. 1960. Azalomycins B and F, two new antibiotics. I. Production and isolation. J. Antibiot., Ser. A 13: 46-50.
2. Arai, M. 1960. Azalomycins B and F, two new antibiotics. II. Properties of azalomycins B and F. J. Antibiot., Ser. A 13: 51-56.
3. Arcamone, F. M., C. Bertazzoli, M. Ghione, and T. Scotti. 1959. Melanosporin and elaiophylin, new antibiotics from Streptomyces melanosporus (sive elanosporofaciens)n. sp. Giorn. Microbiol. 7: 207-216.
4. Barry, A. L., L. Creitz, and R. R. Packer. 1985. Feasibility study of disk diffusion susceptibility tests with Mueller-Hinton Broth solidified with Gelrite, an agar substitute. J. Clin. Microbiol. 21: 409-414.
5. Fiedler, H. P., W. Worner, H. Zahmer, H. P. Kaiser, W. Keller-Schierlein, and A. Muller. 1981. Metabolic products of M/Os. 200. Isolation and characterization of niphithricins A, B, and Elaiophylin, antibiotics produced by Streptomyces violaceoniger. J. Antibiot. 34: 1107-1118.
6. Fukushima, K., T. Arai, S. Iwasaki, M. Namikoshi, and S. Okuda. 1982. Studies on macrocyclic lactone antibiotics. VI. Skeletal structure of copiamycin. J. Antibiot. 35: 1480-1494.
7. Gerlitz, M., P. Hamman, R. Thiericke, and J. Rohr. 1992. The Biogenetic origin of the carbon skeleton and the oxygen atoms of elaiophylin, a symmetric macrodiolide antibiotic. J. Org. Chem. 57: 4030-4033.
8. 15N) nitrate in biological fluids. Anal. Biochem. 126: 131-138.
9. Ivanova, V., R. Rachev, R. Gesheva, M. Darakchieva, P. Panaiotov, D. Belomejova, T. Ivanova, and R. Genkova. 1983. Identification of the antibacterial antibiotic 56-62 and the dynamics of its biosynthesis by an Actinomyces hygroscopicus strain. Acta. Microbiol. Bulg. 12: 24-31.
10. 5a. Chem. Pharm. Bull. 30: 4006-4014.
11. 4a. Chem. Pharm. Bull. 30: 1669-1673.
12. James, F. K. Jr., R. L. J. Jack, and L. F. Paul. 1995. Nitric oxide: A new paradigm for second messengers. J. Med. Chem. 38: 4343-4362.
13. Kaiser, H. P. and W. Keller-Schierlein. 1981. 41. Stoffwechsel-produkte von Mikroorganismen. 202. Strukturaufklarung von Elaiophylin: Spektroskopische Untersuchung und Abbau. Helv. Chim. Acta. 64: 407-424.
14. Lee, S. Y., S. C. Ha, Y. H. Kim, J. J. Lee, and S. D. Hong. 1996. Identification and culture condition of Streptomyces sp. MCY-846 producing elaiophylins. J. Microbiol. Biotechnol. Submitted.
15. Marnett, L. J. 1992. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52: 5575-5589.
16. 2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 49: 105-115.
17. Radomski, M. W., R. M. J. Palmer, and S. Moncada. 1990. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87: 10043-10047.
18. Skehan, P., R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, and M. R. Boyd. 1990. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer. Inst. 82: 1107-1112.
19. Sokolic, M., V. Pokorni, and F. H. Johamnsen. 1992. Liquid chromatographic method for separation and determination of elaiophylin in biotechnology process of salinomycin production. J. Pharm. Biomed. Anal. 10: 989-994.